share_log

Taro Pharmaceutical Indus Analyst Ratings

Benzinga Analyst Ratings ·  Jan 25, 2023 06:14
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
01/25/2023 14.19% HC Wainwright & Co. $54 → $35 Maintains Buy
08/15/2022 76.18% HC Wainwright & Co. $73 → $54 Maintains Buy
01/31/2022 138.17% HC Wainwright & Co. $75 → $73 Maintains Buy
01/18/2022 144.7% HC Wainwright & Co. $82 → $75 Maintains Buy
07/28/2021 167.54% HC Wainwright & Co. $80 → $82 Maintains Buy
06/02/2021 161.01% HC Wainwright & Co. $81 → $80 Maintains Buy
02/01/2021 164.27% HC Wainwright & Co. $80 → $81 Maintains Buy
11/23/2020 161.01% HC Wainwright & Co. $82 → $80 Maintains Buy
07/27/2020 167.54% HC Wainwright & Co. $96 → $82 Maintains Buy
05/21/2020 213.21% HC Wainwright & Co. $94 → $96 Reiterates → Buy
02/04/2020 206.69% HC Wainwright & Co. $110 → $94 Maintains Buy
03/12/2018 304.57% HC Wainwright & Co. → $124 Initiates Coverage On → Buy

What is the target price for Taro Pharmaceutical Indus (TARO)?

There is no price target for Taro Pharmaceutical Indus

What is the most recent analyst rating for Taro Pharmaceutical Indus (TARO)?

There is no analyst for Taro Pharmaceutical Indus

When is the next analyst rating going to be posted or updated for Taro Pharmaceutical Indus (TARO)?

There is no next analyst rating for Taro Pharmaceutical Indus

Is the Analyst Rating Taro Pharmaceutical Indus (TARO) correct?

There is no next analyst rating for Taro Pharmaceutical Indus

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment